KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
KDNY
Delisted
KDNY was delisted on the 10th of August, 2023.
89 hedge funds and large institutions have $271M invested in Chinook Therapeutics, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 40 increasing their positions, 21 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
89
Holders Change
-3
Holders Change %
-3.26%
% of All Funds
2.04%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
40
Reduced
21
Closed
14
Calls
$305K
Puts
$205K
Net Calls
+$100K
Net Calls Change
-$239K
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$10M |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$8.08M |
| 3 |
BlackRock
New York
|
+$8.07M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.46M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2M |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$15.8M |
| 2 |
Millennium Management
New York
|
-$8.7M |
| 3 |
HMC
Harvard Management Company
Boston,
Massachusetts
|
-$5.84M |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$4.65M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
-$3.57M |
